Long COVID ‘hits’ women more than men: study – El Financiero

Women are significantly more likely to suffer from so-called COVID long or persistent than men, revealed a recent review of studies published in the journal “Current Medical Research and Opinion.”

Is considered syndrome of COVID prolonged when a person has some sequelae such as extreme fatigue, dyspnea, moodiness, pulmonary fibrosis, postviral or inflammatory myocarditis, sleep disturbances, memory impairment, chronic kidney disease for more than four weeks from the onset of symptoms caused by the virus of SARS-CoV-2.

“Differences in immune system function between women and men could be an important driver of sex differences in the long-term syndrome of COVID-19. Females develop faster and more robust innate and adaptive immune responses, which can protect them from initial infection and severity. However, this same difference may make women more vulnerable to long-term autoimmune diseases,” the analysis indicated.

Researchers from the Johnson & Johnson Women’s Health Office of the Chief Physician team conducted data analysis on approximately 1.3 million patients, where they found that women who have long COVID present inconvenience ear, nose, and throat disorders, as well as fatigue, mood, neurological, skin, gastrointestinal, and rheumatological disorders.

On the other hand, men are more likely to have some endocrine disorders such as diabetes, as well as problems renal.

“In patients experiencing long COVID syndrome, ENT, GI, psychiatric/mood, dermatologic, neurologic, and other complications (primarily rheumatologic complications and fatigue) were significantly more likely in female patients, while endocrine and renal failure were significantly more likely in male patients,” the researchers noted.

Regarding vaccination, the researchers noted that people who received the inoculation are less likely to have prolonged COVID; however, this could not be evaluated in the prevalence of long COVID by sex.

“Evidence from some, but not all, studies suggests that the people who receive COVID-19 vaccine and subsequently become infected with SARS-CoV-2 are less likely to experience symptoms of long-term COVID syndrome than unvaccinated people,” they wrote.

–